We are live on ! Find out more
NCM

Northroad Capital Management Portfolio holdings

AUM $43.8M Turnover 28.3%
1-Year Est. Return 1.99%
This Fund
S&P 500
This Quarter Est. Return
-6.16%
1 Year Est. Return
+1.99%
3 Year Est. Return
+0.16%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$170M
AUM Growth
-$24.8M
Cap. Flow
-$2.92M
Cap. Flow %
-1.72%
Top 10 Hldgs %
34.22%
Holding
59
New
3
Increased
5
Reduced
48
Closed
3
Avg Time Held
1.8 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
1.6 years

Top Sells

Rank Stock Value
1
MKTAY
MAKITA CORP SPONS ADR
MKTAY
+$3.19M
2
NVS icon
Novartis
NVS
+$1.6M
3
EBAY icon
eBay
EBAY
+$444K
4
DEO icon
Diageo
DEO
+$396K
5
MCD icon
McDonald's
MCD
+$383K

Sector Composition

Rank Sector Weight
1 Miscellaneous 30.9%
2 Financials 16.35%
3 Technology 12.63%
4 Healthcare 12.26%
5 Energy 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DEO icon
1
Diageo
DEO
$52.3B
$7.68M 4.53%
71,282
-3,564
-5% -$396K
2013 Q2
9 quarters
TEL icon
2
TE Connectivity
TEL
$60.7B
$6.46M 3.81%
107,830
+13,984
+15% +$851K
2014 Q4
3 quarters
NVS icon
3
Novartis
NVS
$287B
$5.64M 3.32%
68,428
-18,014
-21% -$1.6M
2013 Q2
9 quarters
MUFG icon
4
Mitsubishi UFJ Financial
MUFG
$246B
$5.46M 3.22%
896,787
-40,124
-4% -$272K
2013 Q2
9 quarters
TTE icon
5
TotalEnergies
TTE
$196B
$5.31M 3.13%
118,809
-5,156
-4% -$243K
2013 Q2
9 quarters
WPP icon
6
WPP
WPP
$5.85B
$5.29M 3.12%
50,839
-2,512
-5% -$274K
2013 Q2
9 quarters
SNY icon
7
Sanofi
SNY
$96.5B
$5.27M 3.11%
111,053
-5,150
-4% -$262K
2013 Q2
9 quarters
SAP icon
8
SAP
SAP
$260B
$5.03M 2.96%
77,629
-3,689
-5% -$255K
2013 Q2
9 quarters
TEVA icon
9
Teva Pharmaceutical Industries Limited
TEVA
$48.2B
$5.03M 2.96%
89,037
-3,696
-4% -$240K
2013 Q2
9 quarters
AXA
10
DELISTED
AXA ADS (1 ORD SHS)
AXA
$4.71M 2.77%
193,409
-9,073
-4% -$221K
2013 Q2
9 quarters
SYT
11
DELISTED
Syngenta Ag
SYT
$4.65M 2.74%
72,936
-3,451
-5% -$263K
2013 Q2
9 quarters
ERIC icon
12
Ericsson
ERIC
$34.2B
$4.45M 2.62%
455,306
+81,134
+22% +$821K
2013 Q2
9 quarters
AKZOY
13
DELISTED
Akzo Nobel NV
AKZOY
$4.42M 2.6%
205,090
-9,099
-4% -$196K
2013 Q2
9 quarters
RDS.A
14
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$4.26M 2.51%
94,837
-4,338
-4% -$220K
2013 Q2
9 quarters
ING icon
15
ING
ING
$94.6B
$4.18M 2.46%
296,013
-14,883
-5% -$234K
2014 Q3
4 quarters
GSK icon
16
GSK
GSK
$98.6B
$4.15M 2.44%
86,290
-4,167
-5% -$217K
2013 Q2
9 quarters
CRH icon
17
CRH
CRH
$54.5B
$4.1M 2.42%
154,572
-6,777
-4% -$196K
2013 Q2
9 quarters
HSBC icon
18
HSBC
HSBC
$324B
$4.1M 2.42%
121,458
-5,607
-4% -$210K
2013 Q2
9 quarters
CS
19
DELISTED
Credit Suisse Group
CS
$4.06M 2.39%
168,774
-7,588
-4% -$208K
2013 Q2
9 quarters
BRG
20
DELISTED
BG GROUP PLC ADS(RP 5 ORD SHS)
BRG
$3.67M 2.16%
251,654
-12,817
-5% -$187K
2015 Q1
2 quarters
BHP icon
21
BHP
BHP
$210B
$3.48M 2.05%
123,400
+30,685
+33% +$997K
2013 Q2
9 quarters
ABB
22
DELISTED
ABB Ltd
ABB
$3.43M 2.02%
193,860
-9,107
-4% -$177K
2013 Q2
9 quarters
BCS icon
23
Barclays
BCS
$76.4B
$3.32M 1.96%
240,569
-12,115
-5% -$186K
2014 Q3
4 quarters
TKP
24
DELISTED
TECHNIP ADS (EA REPTG ONE ORD SHS)
TKP
$2.77M 1.63%
234,978
+40,484
+21% +$477K
2013 Q4
7 quarters
HIT icon
25
DELISTED
HITACHI LTD ADR (10COM)NEW
HIT
$2.72M 1.6%
+53,796
New +$2.72M
2015 Q3
0 quarters

Similar funds

Northroad Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Northroad Capital Management held 59 positions worth $170M, down 13% from $195M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Northroad Capital Management's Q3 2015 filing shows 3 new, 5 increased, 48 reduced and 3 closed positions. Its largest new stake was HITACHI LTD ADR (10COM)NEW: 53,796 shares worth $2.72M. The largest sale was MAKITA CORP SPONS ADR, an estimated $3.19M.

By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, down from 32% a quarter earlier, followed by Financials and Technology.

  • Northroad Capital Management's largest Q3 2015 buy was HITACHI LTD ADR (10COM)NEW: 53,796 shares worth $2.72M.
  • Northroad Capital Management added most to BHP in Q3 2015, an estimated $997K increase.
  • Northroad Capital Management's biggest Q3 2015 reduction was Novartis, cutting an estimated $1.6M.
  • Northroad Capital Management fully exited MAKITA CORP SPONS ADR in Q3 2015, selling an estimated $3.19M.
  • Northroad Capital Management's ten largest holdings make up 34% of its $170M portfolio in Q3 2015.
  • Northroad Capital Management opened 3 new positions and closed 3 in Q3 2015.
  • Northroad Capital Management's portfolio value fell 13% quarter-over-quarter to $170M.

Based on Northroad Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.